Extracellular glutathione peroxidase (GPX3) was downregulated in cancer samples but was upregulated in the cluster 2 patients with higher TME content and metabolic activity, and is considered a prognostic gene in gastric patients (Chang et al., 2020). The gene discussed is GPX3; the disease is cancer.